Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Brucella suis-infected meat imported to UK
‘The presence of B suis in imported raw food is a risk to dogs which are fed this meat. It is also a risk to people handling the meat.'
Small number of affected pet owners and retailers contacted 

Consignments of meat infected with Brucella suis have been imported to the UK for use in raw pet food, highlighting an additional risk of raw feeding, the APHA has revealed.

The UK was notified last month that some consignments of imported frozen hare meat may have come from B suis-infected hares. Writing in Vet Record, the APHA said the product was bought by a very small number of pet owners and retailers, and a recall has already been undertaken.

B suis was detected in the meat after a dog in the Netherlands tested positive for B suis biovar 1, which is ‘highly pathogenic, causing severe disease in human beings’, according to the European Food Safety Authority (2009). Dutch authorities tested the meat consumed by the dog and identified the same type of B suis.

The hare meat in question originated in Argentina and was initially imported to the Netherlands. Parts of three consignments were later imported from the Netherlands to the UK between November 2016 and May 2017. Some of the meat was also exported to four other EU member states.

Andrew Frost, of the APHA, wrote in Vet Record: ‘The presence of B suis in imported raw food is a risk to dogs which are fed this meat. It is also a risk to people handling the meat and, if the dogs become infected, people and other animals are at risk of contracting B suis from the infected dogs themselves. Infected dogs may shed B suis before clinical signs occur.’

A UK company bought all three consignments and once it became aware of the situation, issued recall letters to the small number of customers involved. Public Health England and the APHA also traced and issued letters to these dog owners, informing them of the risks to humans and animals and advising them to contact their vet.

Veterinary surgeons approached by these clients should be presented with the letter, which explains how to proceed. They are also advised to take appropriate precautions to avoid becoming infected. Clinical signs of B suis, which may take several weeks or months to present, may include spondylitis or lameness. Orchitis, abortion and fever may also be seen.

To date, APHA says there are no confirmed or suspected cases of B suis in people, dogs or other animals in the UK and the company involved has ceased to import the non-EU hare meat.

B suis is reportable in pigs, but not dogs. However, veterinary surgeons are asked to notify the APHA of any positive test results for Brucella.    

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.